More Globe Newswire

View Older Stories View Newer Stories

Sep 17, 2025 08:30AM Latin Metals Provides Update on Esperanza Project, San Juan, Argentina
Sep 17, 2025 08:30AM Streamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Toke
Sep 17, 2025 08:30AM Vivakor Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Sep 17, 2025 08:30AM Safety Shot Announces Strategic Board Refresh to Align with New Corporate Vision
Sep 17, 2025 08:30AM Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
Sep 17, 2025 08:30AM Chaince Securities LLC Serves as Exclusive Placement Agent in Trident Digital Tech Holdings’ $2.6 Million Private Placement
Sep 17, 2025 08:30AM Fluent Named to Crain’s New York Business 2025 Best Places to Work List
Sep 17, 2025 08:30AM Biostate AI Launches K-Dense Beta, an AI Agent That Compresses Research Cycles from Years to Days; Validated with Harvard Longevity Discovery Breakthrough
Sep 17, 2025 08:22AM BTXSGG Unveils AI Assistant™ to Democratize Institutional-Grade Trading Intelligence for All Crypto Investors
Sep 17, 2025 08:19AM Progressive Reports August 2025 Results
Sep 17, 2025 08:16AM Shibo Unveils Next Phase of Web3 Impact With Doginal Dogs and Global Events
Sep 17, 2025 08:15AM Form 8.3 - Unite Group Plc
Sep 17, 2025 08:15AM Data443 Announces Strategic Deal with Trium Cyber to Deliver Cyber Insurance Risk Intelligence for Syndicate 1322 of Lloyd's of London
Sep 17, 2025 08:15AM Norwood Financial Corp Announces Cash Dividend
Sep 17, 2025 08:15AM Lewis J. Critelli to Retire as Chairmen of the Board of Norwood Financial Corp; Dr. Andrew A. Forte Appointed Chairman of the Board; Dr. Marissa Nacinovich and James Shook Appointed to the Board
Sep 17, 2025 08:15AM Data443 Announces Strategic Deal with Trium Cyber to Deliver Cyber Insurance Risk Intelligence for Syndicate 1322 of Lloyd's of London
Sep 17, 2025 08:14AM Form 8.3 - Life Science REIT Plc
Sep 17, 2025 08:15AM Capgemini obtains all regulatory approvals for the acquisition of WNS
Sep 17, 2025 08:12AM Form 8.3 - Empiric Student Property Plc
Sep 17, 2025 08:11AM Convergent Wealth Advisors (CNWA) and RealSimple Crypto Exchange (RSCX) Issue Statement Against Fraudulent Scam Allegations
Sep 17, 2025 08:05AM NANO Nuclear Signs Letter of Intent with Cambridge Atom Works to Sell its Portable ODIN™ Reactor Technology
Sep 17, 2025 08:05AM 1PointFive and NYK Announce Carbon Removal Agreement
Sep 17, 2025 08:05AM Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
Sep 17, 2025 08:04AM Bridger Aerospace Applauds Wildland Fire Service Plan and Fire Ready Nation Act
Sep 17, 2025 08:01AM Alm. Brand A/S announces results of its tender offer for outstanding DKK tier 2 capital notes
Sep 17, 2025 08:01AM TZNXG Launches Professional Suite with OTC Trading Desk and Dedicated Relationship Managers
Sep 17, 2025 08:00AM Ninepoint Launches Global Select Fund Featuring Lead Portfolio Manager, Sam Mitter, to Capture Global Growth Opportunities
Sep 17, 2025 08:00AM Rio Silver Amends Maria Norte Terms
Sep 17, 2025 08:00AM Integral Metals Provides Update on 2025 Drilling Program at the KAP Project, Northwest Territories
Sep 17, 2025 08:00AM NEXVOLT Finance Academy Launches "Investor Transparency Initiative" to Combat Financial Misinformation in Europe
Sep 17, 2025 08:00AM Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services
Sep 17, 2025 08:00AM Kestra Medical Technologies Appoints Dr. Elizabeth Kwo to Board of Directors
Sep 17, 2025 08:00AM IQST – IQSTEL Targets $15M EBITDA by 2026 and $1B Revenue by 2027, Showcases Growth Strategy and Leadership in New Interview
Sep 17, 2025 08:00AM HydroGraph Adds Nuclear Industry Expert and Shareholder Kerry Landis to Its Board
Sep 17, 2025 08:00AM Cidara Therapeutics Presents Data on CD388 from its Phase 2b NAVIGATE Trial and Preclinical Studies Against H5N1 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
Sep 17, 2025 08:00AM Allarity Therapeutics CEO to Present at Biomarkers & Precision Medicine 2025
Sep 17, 2025 08:00AM Global Uranium Corp. Reports Results of Airborne ZTEM Survey at Astro Project, Athabasca Basin
Sep 17, 2025 08:00AM Carpenter Technology Announces GICS Aerospace & Defense Sector Reclassification
Sep 17, 2025 08:00AM Cerence AI Collaborates with DSP Concepts to Revolutionize In-Car Audio
Sep 17, 2025 08:00AM Hallucinogenics Marks Two Years Since Launching Online Platform
Sep 17, 2025 08:00AM Asia Broadband in Advanced Licensing Negotiations with Top-Tier Miners
Sep 17, 2025 08:00AM Rgenta Therapeutics Receives Orphan Drug Designation from the U.S. FDA for RGT-61159 for the Treatment of Adenoid Cystic Carcinoma (ACC)
Sep 17, 2025 08:00AM TransUnion Research Highlights Power of Public Data in Uncovering $3.3B Synthetic Identity Threat
Sep 17, 2025 08:00AM SHARC Energy Named Cohort 2 Finalist in New York Climate Exchange’s Sustainable Solutions Challenge
Sep 17, 2025 08:00AM Karbon-X Corp. Files Year-End Financial Results
Sep 17, 2025 08:00AM Preferred Bank Announces Cash Dividend
Sep 17, 2025 08:00AM Building a Globally Trusted Blockchain Financial Platform, Ushering in a New Era of Digital Asset Trading – TokenGo Officially Launches Operations
Sep 17, 2025 08:00AM NEXVOLT Finance Academy Launches "Investor Transparency Initiative" to Combat Financial Misinformation in Europe
Sep 17, 2025 08:00AM JQRBT CRYPTO GROUP Addresses Market Misinformation with Enhanced Transparency and Verifiable U.S. Compliance
Sep 17, 2025 08:00AM AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)
View Newer Stories View Older Stories